Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

Alan Lyles

doi:10.1016/j.clinthera.2007.09.014

Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

Alan Lyles

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	2094-2095
Number of pages	2
Journal	Clinical therapeutics
Volume	29
Issue number	9
DOIs	https://doi.org/10.1016/j.clinthera.2007.09.014
State	Published - Sep 2007

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1016/j.clinthera.2007.09.014

Cite this

@article{63d3175d1a1542d89125b8e3ed7ac56f,

title = "Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?",

author = "Alan Lyles",

year = "2007",

month = sep,

doi = "10.1016/j.clinthera.2007.09.014",

language = "English (US)",

volume = "29",

pages = "2094--2095",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "9",

}

TY - JOUR

T1 - Public administration and public policy

T2 - Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

AU - Lyles, Alan

PY - 2007/9

Y1 - 2007/9

UR - http://www.scopus.com/inward/record.url?scp=36749103199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749103199&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2007.09.014

DO - 10.1016/j.clinthera.2007.09.014

M3 - Article

AN - SCOPUS:36749103199

SN - 0149-2918

VL - 29

SP - 2094

EP - 2095

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 9

ER -

Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this